HEXO — Hexo Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
- CA$38.72m
- CA$198.54m
- CA$191.10m
2018 July 31st | 2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS/A | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4.93 | 47.5 | 80.8 | 124 | 191 |
Cost of Revenue | |||||
Gross Profit | 2.84 | 21.3 | -46.4 | 29.1 | -91.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 22.9 | 135 | 612 | 209 | 1,259 |
Operating Profit | -18 | -87 | -531 | -85.3 | -1,068 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -23.3 | -87.8 | -553 | -115 | -1,112 |
Provision for Income Taxes | |||||
Net Income After Taxes | -23.3 | -69.6 | -546 | -115 | -1,074 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -23.3 | -69.6 | -546 | -115 | -1,068 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -23.3 | -69.6 | -546 | -115 | -1,068 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.2 | -18.9 | -54.3 | -11 | -19.2 |